Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Wentao Sang"'
Autor:
Luyao Gao, Yuan Bian, Shengchuan Cao, Wentao Sang, Qun Zhang, Qiuhuan Yuan, Feng Xu, Yuguo Chen
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Background: Patients with acute heart failure (AHF) who require continuous renal replacement therapy (CRRT) have a high risk of in-hospital mortality. It is clinically important to screen high-risk patients using a model or scoring system. This study
Externí odkaz:
https://doaj.org/article/a0cf0dad7b754d85967f2cb7cd9b5192
Autor:
Xiangkai Zhao, Jian Zhang, Jialin Guo, Jinxin Wang, Yuhui Pan, Xue Zhao, Wentao Sang, Kehui Yang, Fengyang Xu, Feng Xu, Yuguo Chen
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Dual antiplatelet therapy combining aspirin with a P2Y12 adenosine diphosphate receptor inhibitor is a therapeutic mainstay for acute coronary syndrome (ACS). However, the optimal choice of P2Y12 adenosine diphosphate receptor inhibitor i
Externí odkaz:
https://doaj.org/article/fce20aef678f460e8f08c68b164ac368
Autor:
Tonghui Xu, Jialin Guo, Maozeng Wei, Jiali Wang, Kehui Yang, Chang Pan, Jiaojiao Pang, Li Xue, Qiuhuan Yuan, Mengyang Xue, Jian Zhang, Wentao Sang, Tangxing Jiang, Yuguo Chen, Feng Xu
Publikováno v:
JCI Insight, Vol 6, Iss 15 (2021)
The mitochondrial enzyme aldehyde dehydrogenase 2 (ALDH2) catalyzes the detoxification of acetaldehyde and endogenous lipid aldehydes. Approximately 40% of East Asians, accounting for 8% of the human population, carry the E504K mutation in ALDH2 that
Externí odkaz:
https://doaj.org/article/e50af833991b49e5bff8f4d24dcbc02f
Autor:
Jian Zhang, Xiangkai Zhao, Yunyun Guo, Zhiping Liu, Shujian Wei, Qiuhuan Yuan, Haixia Shang, Wentao Sang, Sumei Cui, Tonghui Xu, Kehui Yang, Jialin Guo, Chang Pan, Jiali Wang, Jiaojiao Pang, Tianrui Han, Yuguo Chen, Feng Xu
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 42:700-716
Background: Clinical studies show that the most common single-point mutation in humans, ALDH2 (aldehyde dehydrogenase 2) rs671 mutation, is a risk factor for the development and poor prognosis of atherosclerotic cardiovascular diseases, but the under
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1106d4333b4239faea8d3f7ca06c3131
https://doi.org/10.1161/atvbaha.121.317204
https://doi.org/10.1161/atvbaha.121.317204
[Research progress of in-hospital mortality risk model in patients with acute myocardial infarction]
Publikováno v:
Zhonghua wei zhong bing ji jiu yi xue. 34(5)
The incidence of in-hospital death in acute myocardial infarction (AMI) is high, which seriously threatens the life and health of patients. At present, many countries and regions have established a variety of objective assessment models for predictin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7629ee86ce5d414d46879eb6e5fa1ac8
https://pubmed.ncbi.nlm.nih.gov/35728862
https://pubmed.ncbi.nlm.nih.gov/35728862
Autor:
Yuguo Chen, Yanyan Ma, Jian Zhang, Wentao Sang, Hongzhi Wu, Fengying Chen, Yaping Hou, Tangxing Jiang, Feng Xu, Kehui Yang
Publikováno v:
Atherosclerosis. 308:50-56
Background and aims In patients with left main coronary artery disease (LMCAD), long-term outcomes after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) compared with coronary artery bypass grafting (CABG) remain controversial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133e372d413b9e951024af615e9b1438
https://doi.org/10.1016/j.atherosclerosis.2020.06.024
https://doi.org/10.1016/j.atherosclerosis.2020.06.024
Autor:
Haixia Shang, Tonghui Xu, Wentao Sang, Zhiping Liu, Jun Ren, Xiao-ran Huang, Li Xue, Jian Zhang, Feng Xu, Sumei Cui, Kehui Yang, Zheng Wang, Jieqiong Yu, Yuguo Chen, Xin Li, Jiaojiao Pang
Publikováno v:
European Heart Journal. 41:2442-2453
Aims Aortic aneurysm/dissection (AAD) is a life-threatening disorder lacking effective pharmacotherapeutic remedies. Aldehyde dehydrogenase 2 (ALDH2) polymorphism is tied with various risk factors for AAD including hypertension, atherosclerosis, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc8d9d84e1840b64fcbe4eecf14be4ce
https://doi.org/10.1093/eurheartj/ehaa352
https://doi.org/10.1093/eurheartj/ehaa352
Autor:
Wentao Sang, Yuhui Pan, Xue Zhao, Shuo Wu, Wen Zheng, Chang Pan, Jiaqi Zheng, Shuxing Wei, Yongsheng Zhang, Jian Zhang, Jingjing Ma, Yuguo Chen, Feng Xu
Background: Early detection and intervention of disease deterioration are the keys to reducing the incidence of preventable intensive care unit cardiac arrest (ICU-CA). We aimed to investigate the ICU-CA predictive factors, including vital signs and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e205de29f363b966714dc446532581c
https://doi.org/10.21203/rs.3.rs-1169878/v1
https://doi.org/10.21203/rs.3.rs-1169878/v1
Autor:
Feng Xu1, Wentao Sang1, Ling Li1, Xinyu He1, Feng Wang1, Taoqun Wen1, Nan Zeng1 zengnan666@126.com
Publikováno v:
Drug & Chemical Toxicology. May2019, Vol. 42 Issue 3, p309-316. 8p.
Autor:
Tonghui Xu, Chang Pan, Maozeng Wei, Jiaojiao Pang, Wentao Sang, Mengyang Xue, Jian Zhang, Li Xue, Jiali Wang, Jialin Guo, Qiuhuan Yuan, Tangxing Jiang, Yuguo Chen, Kehui Yang, Feng Xu
Publikováno v:
JCI Insight
The mitochondrial enzyme acetaldehyde dehydrogenase 2 (ALDH2) catalyzes the detoxification of acetaldehyde and endogenous lipid aldehydes. Approximately 40% of East Asians, accounting for 8% of the human population, carry the E504K mutation in ALDH2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b84b0746738381f3070e01a83c64d00
https://doi.org/10.1172/jci.insight.138183
https://doi.org/10.1172/jci.insight.138183